OnKure Therapeutics, Inc. ($OKUR)
Filing Information
| Accession Number | 0001692747-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 11, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
333,428
Total Value
$0.00
P&L
+inf% (+$147,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Employee Stock Option (right to buy) | Derivative | Aug 7, 2026 | Grant/Award | 50,000 | $0.00 | $0.00 | 50,000 | Direct | โ | View Details | |
Chief Financial Officer | Employee Stock Option (right to buy | Derivative | Aug 7, 2026 | Sale to Issuer | 5,781 | โ | โ | 0 | Direct | โ | View Details | |
Chief Financial Officer | Employee Stock Option (right to buy | Derivative | Aug 7, 2026 | Grant/Award | 5,781 | โ | โ | 5,781 | Direct | โ | View Details | |
Chief Financial Officer | Employee Stock Option (right to buy) | Derivative | Aug 7, 2026 | Sale to Issuer | 5,322 | โ | โ | 0 | Direct | โ | View Details | |
Chief Financial Officer | Employee Stock Option (right to buy) | Derivative | Aug 7, 2026 | Grant/Award | 5,322 | โ | โ | 5,322 | Direct | โ | View Details | |
Chief Financial Officer | Employee Stock Option (right to buy) | Derivative | Aug 7, 2026 | Sale to Issuer | 130,611 | โ | โ | 0 | Direct | โ | View Details | |
Chief Financial Officer | Employee Stock Option (right to buy) | Derivative | Aug 7, 2026 | Grant/Award | 130,611 | โ | โ | 130,611 | Direct | โ | View Details |